Apologies, I found the full year 2023 stuff which has not been posted here in HC, other stuff is missing too, which is strange:
In 2022 EYE had revenues (sales/gross income) of $13.378 mil and a net loss of $7.817 - expenses of $21.195 mil.
In 2023 EYE had revenue of $17 mil and a loss of $17 mil, so expenses of $34 mil, of which there was $6.044 mil recorded as a one off impairment, obviously with normalised expenses of $28 mil.
In 2024 income has been $23.5 mil, so it remains to be seen how much expenses have risen. They are expected to have risen substantially and there will be a significant loss.
*The impairment item was due to the inability of the AlphaRET segment to generate independent cashflows, requiring a cash investment of $6.044 mil, more than the company has available. Not quite a one off non cash item as characterised by TheAnalyst007
- Forums
- ASX - By Stock
- EYE
- EYE Summary (August 2024): Incredibly Undervalued
EYE
nova eye medical limited
Add to My Watchlist
0.00%
!
12.5¢

EYE Summary (August 2024): Incredibly Undervalued, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
12.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.51M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 49999 | 13.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 70999 | 0.130 |
3 | 53976 | 0.125 |
9 | 709992 | 0.120 |
1 | 201331 | 0.115 |
5 | 721828 | 0.110 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 50000 | 1 |
0.135 | 249802 | 7 |
0.140 | 346515 | 3 |
0.145 | 315000 | 2 |
0.150 | 156000 | 4 |
Last trade - 09.59am 08/07/2025 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
The Watchlist
AGC
AUSTRALIAN GOLD AND COPPER LTD
Glen Diemar, MD
Glen Diemar
MD
SPONSORED BY The Market Online